View in EDS HTML Full Text PDF Full Text

Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study.

Saved in:
Bibliographic Details
Title: Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study.
Authors: Farooq, Abdullah (AUTHOR), Valerio, Heather (AUTHOR), Wheeler, Alice (AUTHOR), Martinello, Marianne (AUTHOR), Henderson, Charles (AUTHOR), Silk, David (AUTHOR), Degenhardt, Louisa (AUTHOR), Read, Phillip (AUTHOR), Dore, Gregory J. (AUTHOR), Grebely, Jason (AUTHOR), Cunningham, Evan B. (AUTHOR), Bath, Nicky (AUTHOR), Treloar, Carla (AUTHOR), Milat, Andrew (AUTHOR), Dunlop, Adrian (AUTHOR), Amin, Janaki (AUTHOR), Holden, Jo (AUTHOR), Murray, Carolyn (AUTHOR), Leadbeatter, Kyle (AUTHOR), Day, Emma (AUTHOR)
Source: Drug & Alcohol Review. May2024, Vol. 43 Issue 4, p1019-1028. 10p.
Subjects: Needle sharing, Hepatitis C virus, Harm reduction, Drugs, Odds ratio
Geographic Terms: Australia
Abstract: Introduction: Understanding needle/syringe sharing is crucial for reducing hepatitis C virus (HCV) infection and reinfection. This study aimed to assess the prevalence and factors associated with needle/syringe sharing among people who inject drugs in Australia, including those previously receiving HCV treatment. Methods: The ETHOS Engage study was an observational cohort study which collected self‐reported survey data on demographic and drug use information from people who inject drugs attending drug treatment clinics and needle and syringe programs over two waves between May 2018 and June 2021. Logistic regression was used to identify factors associated with needle/syringe sharing. Results: Overall, 1555/2395 people enrolled in ETHOS Engage (65%) injected drugs in the past month. Among these, 432 (28%) reported needle/syringe sharing in the past month and 276 (18%) reported receptive sharing. Factors associated with receptive sharing included younger age (adjusted odds ratio [aOR] 1.72; 95% confidence interval [CI] 1.28–2.30), recent incarceration (aOR 2.04; 95% CI 1.40–2.94), more frequent injecting (≥daily vs. less than weekly; aOR 2.59; 95% CI 1.75–3.84) and unstable housing (aOR 1.78; 95% CI 1.26–2.52). Among 560 participants with prior HCV treatment, 87 (16%) reported receptive sharing with younger age (aOR 2.42; 95% CI 1.45–4.05) and daily or greater injection frequency (aOR 2.51; 95% CI 1.31–4.83) associated with receptive sharing. Discussion and Conclusions: Needle/syringe sharing was common among this population accessing harm reduction services. This study identifies high‐risk populations with needle/syringe sharing. Research is needed to optimise HCV treatment to ensure people with ongoing risk behaviours receive adequate harm reduction following treatment to prevent reinfection. [ABSTRACT FROM AUTHOR]
Copyright of Drug & Alcohol Review is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 176870002
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Farooq%2C+Abdullah%22">Farooq, Abdullah</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Valerio%2C+Heather%22">Valerio, Heather</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wheeler%2C+Alice%22">Wheeler, Alice</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Martinello%2C+Marianne%22">Martinello, Marianne</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Henderson%2C+Charles%22">Henderson, Charles</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Silk%2C+David%22">Silk, David</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Degenhardt%2C+Louisa%22">Degenhardt, Louisa</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Read%2C+Phillip%22">Read, Phillip</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dore%2C+Gregory+J%2E%22">Dore, Gregory J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Grebely%2C+Jason%22">Grebely, Jason</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cunningham%2C+Evan+B%2E%22">Cunningham, Evan B.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bath%2C+Nicky%22">Bath, Nicky</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Treloar%2C+Carla%22">Treloar, Carla</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Milat%2C+Andrew%22">Milat, Andrew</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dunlop%2C+Adrian%22">Dunlop, Adrian</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Amin%2C+Janaki%22">Amin, Janaki</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Holden%2C+Jo%22">Holden, Jo</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Murray%2C+Carolyn%22">Murray, Carolyn</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Leadbeatter%2C+Kyle%22">Leadbeatter, Kyle</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Day%2C+Emma%22">Day, Emma</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Drug+%26+Alcohol+Review%22">Drug & Alcohol Review</searchLink>. May2024, Vol. 43 Issue 4, p1019-1028. 10p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Needle+sharing%22">Needle sharing</searchLink><br /><searchLink fieldCode="DE" term="%22Hepatitis+C+virus%22">Hepatitis C virus</searchLink><br /><searchLink fieldCode="DE" term="%22Harm+reduction%22">Harm reduction</searchLink><br /><searchLink fieldCode="DE" term="%22Drugs%22">Drugs</searchLink><br /><searchLink fieldCode="DE" term="%22Odds+ratio%22">Odds ratio</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Australia%22">Australia</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Introduction: Understanding needle/syringe sharing is crucial for reducing hepatitis C virus (HCV) infection and reinfection. This study aimed to assess the prevalence and factors associated with needle/syringe sharing among people who inject drugs in Australia, including those previously receiving HCV treatment. Methods: The ETHOS Engage study was an observational cohort study which collected self‐reported survey data on demographic and drug use information from people who inject drugs attending drug treatment clinics and needle and syringe programs over two waves between May 2018 and June 2021. Logistic regression was used to identify factors associated with needle/syringe sharing. Results: Overall, 1555/2395 people enrolled in ETHOS Engage (65%) injected drugs in the past month. Among these, 432 (28%) reported needle/syringe sharing in the past month and 276 (18%) reported receptive sharing. Factors associated with receptive sharing included younger age (adjusted odds ratio [aOR] 1.72; 95% confidence interval [CI] 1.28–2.30), recent incarceration (aOR 2.04; 95% CI 1.40–2.94), more frequent injecting (≥daily vs. less than weekly; aOR 2.59; 95% CI 1.75–3.84) and unstable housing (aOR 1.78; 95% CI 1.26–2.52). Among 560 participants with prior HCV treatment, 87 (16%) reported receptive sharing with younger age (aOR 2.42; 95% CI 1.45–4.05) and daily or greater injection frequency (aOR 2.51; 95% CI 1.31–4.83) associated with receptive sharing. Discussion and Conclusions: Needle/syringe sharing was common among this population accessing harm reduction services. This study identifies high‐risk populations with needle/syringe sharing. Research is needed to optimise HCV treatment to ensure people with ongoing risk behaviours receive adequate harm reduction following treatment to prevent reinfection. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Drug & Alcohol Review is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=176870002
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/dar.13828
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 10
        StartPage: 1019
    Subjects:
      – SubjectFull: Needle sharing
        Type: general
      – SubjectFull: Hepatitis C virus
        Type: general
      – SubjectFull: Harm reduction
        Type: general
      – SubjectFull: Drugs
        Type: general
      – SubjectFull: Odds ratio
        Type: general
      – SubjectFull: Australia
        Type: general
    Titles:
      – TitleFull: Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Farooq, Abdullah
      – PersonEntity:
          Name:
            NameFull: Valerio, Heather
      – PersonEntity:
          Name:
            NameFull: Wheeler, Alice
      – PersonEntity:
          Name:
            NameFull: Martinello, Marianne
      – PersonEntity:
          Name:
            NameFull: Henderson, Charles
      – PersonEntity:
          Name:
            NameFull: Silk, David
      – PersonEntity:
          Name:
            NameFull: Degenhardt, Louisa
      – PersonEntity:
          Name:
            NameFull: Read, Phillip
      – PersonEntity:
          Name:
            NameFull: Dore, Gregory J.
      – PersonEntity:
          Name:
            NameFull: Grebely, Jason
      – PersonEntity:
          Name:
            NameFull: Cunningham, Evan B.
      – PersonEntity:
          Name:
            NameFull: Bath, Nicky
      – PersonEntity:
          Name:
            NameFull: Treloar, Carla
      – PersonEntity:
          Name:
            NameFull: Milat, Andrew
      – PersonEntity:
          Name:
            NameFull: Dunlop, Adrian
      – PersonEntity:
          Name:
            NameFull: Amin, Janaki
      – PersonEntity:
          Name:
            NameFull: Holden, Jo
      – PersonEntity:
          Name:
            NameFull: Murray, Carolyn
      – PersonEntity:
          Name:
            NameFull: Leadbeatter, Kyle
      – PersonEntity:
          Name:
            NameFull: Day, Emma
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 09595236
          Numbering:
            – Type: volume
              Value: 43
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Drug & Alcohol Review
              Type: main
ResultId 1